A financial engineering move and an analyst's price target cut dampened sentiment on the company.Over the past five days, the struggling marijuana industry was perfectly exemplified by Tilray Brands (TLRY +1.80%). A major financial engineering effort by the company kicked in on Monday, and it dragged the stock down over the subsequent trading sessions. This was reinforced by a price target cut from an analyst. According to data compiled by S&P Global Market Intelligence, Tilray's stock tumbled by almost 10% ...

Core Viewpoint - Investors may need to consider cutting losses as Tilray Brands has lost about 90% of its market value over the past five years due to subpar financial results and a challenging regulatory environment [1] Group 1: Market Performance - Tilray's stock has gained 90% in the past six months in anticipation of potential marijuana legalization in the U.S. [3] - The current market capitalization of Tilray is $8 billion, with a day's trading range between $6.90 and $7.10 [4] Group 2: Legalization Impact - Federal legalization of cannabis in the U.S. could provide significant opportunities for Tilray, allowing easier access to banking services and interstate shipping [1][2] - The company has a strong presence in the U.S. market, particularly through its craft brewing business, positioning it well to capitalize on legalization [2] Group 3: Uncertainties and Risks - There are concerns about whether legalization will truly benefit Tilray, as similar developments in Canada did not lead to profitability [4] - The future of Tilray remains uncertain due to unanswered questions regarding regulatory oversight, competition from larger corporations, and consumer behavior changes [4]

At one point this year, the cannabis producer's stock was up as much as 58%.Investing in the cannabis industry comes with significant risks, and you need to be prepared for a lot of volatility. Tilray Brands (TLRY 8.43%) is a prime example of why that is. Although it's a leading cannabis producer in Canada, it has been anything but a good buy over the years. It's down more than 91% over the past five years. Although it was rallying earlier this year based on hopes related to easing restrictions on marijuana ...

ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is pleased to unveil the Ultimate 2025 Holiday Drink Gift Guide—a curated collection of the season’s most giftable craft beers, premium spirits, ready-to-drink cocktails, and hemp-derived beverages designed to elevate gatherings and spark moments of connection across North Ameri ...

TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today released its 2025 Cannabis Holiday Gift Guide, showcasing Canadians’ top picks for gifting, entertaining, and seasonal celebrations. With cannabis now firmly embedded in Canada’s holiday culture, the guide arrives ahead of one of the industry’s busiest retail periods. Acc ...

Key Takeaways Tilray is pressured by a stricter U.S. hemp definition and a recent 1-for-10 reverse stock split.The new rule threatens low-dose THC beverages, a small but fast-growing category for Tilray.Tilray's cannabis sales rose on stronger Canadian adult-use demand and expanding international markets.Shares of Tilray Brands (TLRY) , one of the most well-known players in the cannabis space, have been declining steadily over the past month.This downside can be attributed to the U.S. legislation passed las ...

Core Insights - Tilray Brands, listed on NASDAQ as TLRY, is a significant player in the cannabis industry, focusing on the production and distribution of medical and recreational cannabis products [1][4] - The company executed a reverse stock split at a ratio of 10 for 1 on December 2, 2025, to consolidate shares and potentially stabilize its stock price [1][4] - Despite the reverse stock split, Tilray's shares have faced a substantial decline, with a nearly 40% loss in 2025 and a recent drop of over 20% in a trading session [2][4] Stock Performance - Following the reverse stock split, the total number of outstanding shares was reduced from approximately 1.16 billion to 116 million [2][4] - Currently, Tilray's stock is priced at $8.64, reflecting a 10.49% increase with a change of $0.82, and a trading volume of 5.37 million shares indicates active investor interest [3] - The stock has experienced significant fluctuations, with a low of $7.17 and a high of $8.95 in a single day, suggesting potential for further selling pressure [3]

In recent years, one of the biggest losers in the market has been Tilray Brands, Inc. ( TLRY ). The Canadian cannabis firm has seen its shares plunge over time as the U.S. government has notI am a market enthusiast and part-time trader. I started writing for Seeking Alpha in 2011, and it has been a tremendous opportunity and learning experience. I have been interested in the markets since elementary school, and hope to pursue a career in the investment management industry. I have been active in the markets ...

Core Insights - The Canadian cannabis sector is experiencing renewed interest from traders and long-term investors despite unpredictable market conditions, with leading companies showing resilience and strategic progress [1][2] - The industry faces challenges such as slower domestic growth, tighter financing conditions, and heavy price competition, but operators are expanding internationally and preparing for potential U.S. policy changes [1][2] - Financial discipline is becoming a key theme, with companies reducing costs and improving margins, indicating signs of maturity in the sector [3] Industry Overview - The global cannabis landscape is evolving, with European countries expanding medical programs and Germany advancing legalization, creating export opportunities for Canadian producers [2] - U.S. federal reform remains uncertain, but companies with indirect exposure to the U.S. market could benefit from any policy changes [2] Company Highlights - **Tilray Brands, Inc.**: Continues to expand internationally while improving financial performance, reporting Q1 fiscal 2026 revenue of approximately $210 million, with positive net income and over $250 million in cash [5][8] - **Canopy Growth Corporation**: Gaining traction after restructuring, with Q2 fiscal 2026 revenue growth driven by Canadian adult-use sales and improved medical demand, alongside a significant reduction in net loss [9][10][11] - **Village Farms International, Inc.**: Transitioned to cannabis cultivation with strong financial performance, reporting double-digit revenue growth and positive net income for multiple quarters, supported by efficient operations and rising international demand [12][14] Financial Performance - Tilray's revenue growth is attributed to stronger Canadian sales and rising international demand, with improved margins and better cost control [8] - Canopy's revenue growth is driven by better brand strength and retail penetration in Canada, with improved gross margins and liquidity [10][11] - Village Farms has shown strong financial performance with high gross margins and positive net income, benefiting from disciplined cost controls and scalable growing capacity [14] Strategic Positioning - Companies are building stronger platforms and expanding their international footprints, positioning themselves for potential U.S. policy shifts [1][2] - Tilray's diverse product portfolio and strong distribution network in Canada and Europe position it well for future growth [5] - Canopy's integrated platform in the U.S. through partnerships provides a strong multi-state reach despite not holding direct cannabis licenses [9][11] - Village Farms' international presence and potential for THC production in the U.S. could enhance its growth prospects [12][14]

Core Insights - The U.S. government is set to impose stricter regulations on hemp-based THC products, potentially banning most hemp-derived products by November 2026, which poses significant challenges for the industry [1][10] - Cannabis companies, including Tilray Brands, have relied on hemp to enter the U.S. market since the 2018 Farm Bill, which created opportunities for growth [2][5] Company Overview: Tilray Brands - Tilray has been expanding its portfolio through acquisitions, particularly in the alcohol sector, and aimed to leverage hemp-based beverages for growth [4][6] - Despite its ambitions, Tilray's management acknowledges that hemp-derived products have not significantly contributed to its business thus far [6][10] - The company has faced difficulties in achieving consistent growth due to a highly competitive Canadian cannabis market and complex international regulations [7][9] Market Performance - Tilray's stock has experienced a significant decline, down approximately 86% over the past five years, with a recent drop of around 37% in the last month [9][11] - The current market capitalization of Tilray is $1 billion, with a stock price of $0.81, reflecting a challenging financial environment [8]